8BU4

Structure of DDB1 bound to DS22-engaged CDK12-cyclin K

8BU4 の概要

• エントリーDOI: 10.2210/pdb8bu4/pdb
• 分子名称: DNA damage-binding protein 1, Cyclin-dependent kinase 12, Cyclin-K, ... (5 entities in total)
• 機能のキーワード: kinase, cyclin, ubiquitin, degrader, ligase
• 由来する生物種: Homo sapiens (human); 詳細
• タンパク質・核酸の鎖数: 9
• 化学式量合計: 499406.71

構造登録者

Kozicka, Z.,Kempf, G.,Focht, V.,Thoma, N.H. (登録日: 2022-11-30, 公開日: 2023-09-13, 最終更新日: 2024-10-16)

主引用文献

Kozicka, Z.,Suchyta, D.J.,Focht, V.,Kempf, G.,Petzold, G.,Jentzsch, M.,Zou, C.,Di Genua, C.,Donovan, K.A.,Coomar, S.,Cigler, M.,Mayor-Ruiz, C.,Schmid-Burgk, J.L.,Haussinger, D.,Winter, G.E.,Fischer, E.S.,Slabicki, M.,Gillingham, D.,Ebert, B.L.,Thoma, N.H.
Design principles for cyclin K molecular glue degraders.
Nat.Chem.Biol., 20:93-102, 2024

PubMed Abstract: Molecular glue degraders are an effective therapeutic modality, but their design principles are not well understood. Recently, several unexpectedly diverse compounds were reported to deplete cyclin K by linking CDK12-cyclin K to the DDB1-CUL4-RBX1 E3 ligase. Here, to investigate how chemically dissimilar small molecules trigger cyclin K degradation, we evaluated 91 candidate degraders in structural, biophysical and cellular studies and reveal all compounds acquire glue activity via simultaneous CDK12 binding and engagement of DDB1 interfacial residues, in particular Arg928. While we identify multiple published kinase inhibitors as cryptic degraders, we also show that these glues do not require pronounced inhibitory properties for activity and that the relative degree of CDK12 inhibition versus cyclin K degradation is tuneable. We further demonstrate cyclin K degraders have transcriptional signatures distinct from CDK12 inhibitors, thereby offering unique therapeutic opportunities. The systematic structure-activity relationship analysis presented herein provides a conceptual framework for rational molecular glue design.

PubMed: 37679459
DOI: 10.1038/s41589-023-01409-z

実験手法

X-RAY DIFFRACTION (3.09 Å)